AAPS to present eLearning Webinar on Nanotechnology in Drug Design and Development

Learning opportunity gives overview of submicron systems, covers analytical issues

WHO: The American Association of Pharmaceutical Scientists (AAPS) is a professional, scientific society of approximately 12,000 members employed in industry, academia, government and other research institutes worldwide. Founded in 1986, AAPS provides a dynamic international forum for the exchange of knowledge among scientists to enhance their contributions to public health. AAPS offers timely scientific programs, on-going education, information resources, opportunities for networking, and professional development.

WHAT: AAPS is pleased to present the complimentary eLearning Webinar on Nanotechnology in Drug Design and Development. This module is funded by a grant from AstraZeneca, and is organized by the AAPS Physical Pharmacy and Biopharmaceutics Section. This Webinar will be conducted by Roy Haskell, Ph.D.

WHY: The purpose of this free Webinar is to provide an overview of submicron systems and to discuss the analytical issues nanotechnology presents, as well as the means by which some of these issues can be addressed. Participants will gain understanding of submicron systems and the context in which the technology can be used in the pharmaceutical sciences.

WHEN: October 22, 2009
12:30 PM to 2:00 PM EDT

CONTACT: For additional information about the workshop, and to register, visit http://www.aapspharmaceutica.com/webinars/nanotechnology. To set up an interview with the Webinar conductor please contact Joe Catapano at 703-248-4772 or [email protected].

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Huntington’s disease symptoms reduced by new peptide-polymer therapy